Beam Therapeutics Inc.

NASDAQ: BEAM
$30.34
-$0.33 (-1.1%)
Closing price March 23, 2023
Wednesday's top analyst upgrades and downgrades included Apple, Boston Scientific, Caterpillar, Ciena, Costco Wholesale, Generac, Hasbro, Rivian Automotive, Steel Dynamics, Tapestry, Trade Desk and...
Tuesday's top analyst upgrades and downgrades included Adobe, Enterprise Products Partners, Fubo TV, Nvidia, SunPower, Target, Verizon Communications and Walmart.
Friday's top analyst upgrades and downgrades included CenterPoint Energy, Cloudflare, Dynavax Technologies, HCA Healthcare, Opendoor Technologies, Roku, Salesforce.com, Spotify Technology and Wheaton...
One of the hottest recent IPOs, Coinbase, reports June-quarter earnings Tuesday afternoon. Coinbase and three other stocks are held in Cathie Wood's ARK ETFs.
Tuesday's top analyst upgrades and downgrades included Alphabet, Bank of America, Boeing, Coinbase, Dollar General, Kroger and McDonald's.
Monday's top analyst upgrades and downgrades included Apache, CME, Cree, On Semiconductor, Pioneer Natural Resources, Plug Power, Sony and Wayfair.
Tuesday's top analyst upgrades and downgrades included American Express, BlackBerry, BP, CrowdStrike, Noble Midstream, Waste Management and Zscaler.
Friday's top analyst upgrades and downgrades included AGCO, Caterpillar, Chewy, Clorox, Costco Wholesale, First Solar, Netflix, Snap, Starbucks and Wynn Resorts.
The analysts at its underwriting firms are quite positive on Beam Therapeutics, now that its post-IPO quiet period has come to an end.
Monday's top analyst upgrades, downgrades and initiations included ABB, Apple, Baidu, Casper Sleep, General Electric, Groupon, JPMorgan, Micron Technology, PPD, Verizon Communications and Wayfair.